Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	233.65	246.99	148.81	245.2	163.24	142.84
Short-Term Investments	16.11	39.21	144.78	237.3	320.03	309.9
Cash & Short-Term Investments	249.76	286.2	293.6	482.5	483.27	452.74
Cash Growth	-10.90%	-2.52%	-39.15%	-0.16%	6.74%	-10.20%
Receivables	98.07	87.63	66.2	52.67	46.92	33.28
Inventory	115.34	59.7	23.82	26.82	19.56	14.04
Prepaid Expenses	35.31	49.53	40.21	34.85	29.72	20.01
Total Current Assets	498.47	483.06	423.82	596.83	579.47	520.07
Property, Plant & Equipment	53.58	57.98	60.31	63.08	67.16	81.02
Goodwill	197.8	197.8	197.8	197.8	197.8	197.8
Other Intangible Assets	18.03	20.49	23	-	-	-
Long-Term Deferred Charges	-	-	-	23	23	23
Other Long-Term Assets	18.68	18.55	19.24	24.43	19.1	28.32
Total Assets	786.56	777.88	724.17	905.14	886.52	850.21
Accounts Payable	13.48	15.12	15.41	21.51	17.06	21.72
Accrued Expenses	132.89	121.44	80.23	87.8	92.75	88.58
Current Portion of Leases	8.54	8.32	8.55	7.41	6.87	7.19
Current Income Taxes Payable	-	12.43	5.94	6.15	-	7.3
Current Unearned Revenue	-	-	-	-	-	1.25
Other Current Liabilities	3.23	10.37	28.88	23.1	12.99	2.77
Total Current Liabilities	158.14	167.69	139.02	145.98	129.68	128.81
Long-Term Debt	389.49	387.86	391.99	389.36	389.25	149.51
Long-Term Leases	46.62	48.88	51.58	43.36	45.6	53.53
Long-Term Unearned Revenue	-	-	-	5.91	7.41	8.91
Long-Term Deferred Tax Liabilities	-	-	-	4.93	4.9	5.05
Other Long-Term Liabilities	13.48	13.28	18.53	8.24	23.3	27.98
Total Liabilities	607.73	617.71	601.12	597.77	600.14	373.78
Common Stock	2.94	2.92	2.82	2.81	2.65	2.6
Additional Paid-In Capital	2,906	2,836	2,665	2,595	2,309	2,227
Retained Earnings	-2,755	-2,684	-2,532	-2,296	-2,045	-1,769
Comprehensive Income & Other	25.04	5.31	-12.02	5.06	20.61	15.21
Shareholders' Equity	178.83	160.17	123.05	307.37	286.38	476.43
Total Liabilities & Equity	786.56	777.88	724.17	905.14	886.52	850.21
Total Debt	444.66	445.06	452.12	440.13	441.73	210.23
Net Cash (Debt)	-194.9	-158.86	-158.53	42.37	41.54	242.52
Net Cash Growth	-	-	-	1.99%	-82.87%	32.95%
Net Cash Per Share	-0.64	-0.54	-0.55	0.16	0.16	1.01
Filing Date Shares Outstanding	298.81	295.38	282.71	280.03	264.32	257.24
Total Common Shares Outstanding	298.69	293.59	281.11	278.91	262.06	255.42
Working Capital	340.34	315.37	284.8	450.86	449.79	391.26
Book Value Per Share	0.60	0.55	0.44	1.10	1.09	1.87
Tangible Book Value	-37	-58.11	-97.75	109.57	88.58	278.63
Tangible Book Value Per Share	-0.12	-0.20	-0.35	0.39	0.34	1.09
Land	-	-	-	3.19	3.19	3.19
Machinery	-	24.15	23.63	25.62	23.94	26.03
Construction In Progress	-	3.81	4.16	8.23	5.87	4.18
Leasehold Improvements	-	28.03	24.16	24.17	24.15	30.29

Source: S&P Capital IQ. Standard template. Financial Sources.